02/05/2022
Opening Pathways to Patient Access
RareiTi deploys managed access programs as a key strategy for opening pathways. Managed access is a broad term for several regulatory routes that are used to provide access to unapproved therapies.
It first came into broad use after the AIDS epidemic with people desperate to get life-saving therapies and now is (or should be) consideration for any company developing a novel therapy. Managed access goes beyond moving an unlicensed drug from point A to point B backed by a strong program of pharmacovigilance.
At RareiTi, we apply global expertise in designing and implementing managed access programs, and we tackle the complex tasks of engaging with regulators, payers, HCPs, patients, and caregivers during enrollment and throughout the life of the program, including the transition to commercialization.
🩺 RealiTi offers digitally driven solutions and strategies to solve specialty medicines access challenges delivering real-world evidence in all treatment settings. Evidence, Insights, Impact. Discover how we can help you at realitihealth.com